Subcutaneous Tumor Model

Hendrerit nunc sociis tortor condimentum purus pellentesque dictum.

Product Details

Tab #1

Tab #2

Tab #1

Tab #2

KCI's subcutaneous tumor platform has comprehensive tumor model resources to meet the needs from high-throughput drug screening to personalized therapy research. We provide professional experimental design, customize experimental protocols according to customer needs, and strictly follow standardized operating procedures (SOPs) to ensure the reliability and reproducibility of experimental results. The platform is also equipped with efficient data analysis capabilities, using an intelligent data management system, combined with multi-dimensional evaluation indicators to comprehensively assess drug efficacy. With rich project experience, we have completed a number of preclinical evaluation projects for antitumor drugs, covering chemotherapeutic drugs, targeted drugs and immunotherapeutic drugs, and have established long-term cooperative relationships with well-known domestic and foreign pharmaceutical companies and research institutions.

Genus	Type	Cell name
Human	Human colon cancer cells	HCT116-LUCI， HT-29， LOVO
	Human pancreatic cancer cells	MIA Paca-2， Capan-1， Capan-2， PANC-1
	Human breast cancer cells	MDA-MB-231-LUCI， MDA-MB-231， MDA-MB-361， HCC1937
	Human macrophage lung cancer cell	NCI-H460
	Human lung cancer cells(lymph node metastasis)	NCI-H292
	Human small cell lung cancer cells	NCI-H446
	Human non-small cell lung cancer cells	A549，HCC827
	Human lung adenocarcinoma cells	NCI-H1975
	Human liver cancer cells	SNU-739
	Human highly metastatic liver cancer cell Line	MHCC97H-LUCI
	Human gastric cancercells	NCI-N87-LUCI
	Human brain glioblastoma cells	U-87MG-LUCI， U-87MG
	Human glioma cells	U251-Luci
	Human bladder cancer cells, or human bladder transitional cell carcinoma cells	T24
Rodent	Mouse colon cancer cells	CT26.WT，MC38
	Mouse lung cancer cells	LLC
	Mouse breast cancer cells	4T1-LUCI，4T1
	Mouse liver cancer cells	Hepa 1-6